Company news
BetterLife Pharma Inc. news in 2020
BetterLife Pharma Inc.'s news releases, calls and decks from 2020, newest first.
CSE Bulletin: Fundamental Change - BetterLife Pharma Inc. (BETR)
August 31, 2020
BetterLife Pharma Provides Update on Proposed Acquisition of Altum and its Regulatory Guidance and Updated Clinical Development Plan
July 27, 2020
BetterLife Pharma Announces Consolidation of its Common Shares
June 24, 2020
CSE Bulletin: Consolidation - BetterLife Pharma Inc. (BETR)
June 23, 2020
BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum
June 11, 2020
BetterLife Pharma Announces OTC Trading Symbol Change to "BETRF" Effective June 9, 2020
June 9, 2020
BetterLife Pharma Secures Lock-Up Agreements From Shareholders of Altum
May 25, 2020
BetterLife Pharma Announces Appointment of Dr. Eleanor Fish, a leading expert on interferon activity against Covid-19, to its Advisory Board
May 19, 2020
BetterLife Pharma announces release of exploratory study on treatment of Covid-19 patients in Wuhan with Interferon
May 15, 2020
BetterLife Pharma announces Interferon Alpha-2b Covid-19 news regarding its emergence as a potential treatment for COVID-19
May 13, 2020
BetterLife Pharma Confirms Re-Pricing of Warrants
May 12, 2020
BetterLife Pharma Highlights Results from Recent Clinical Reports and Studies on use of Interferon and Announces Appointment of Dr. Mark Swaim and Engagement of IR Group
May 11, 2020
BetterLife Pharma Enters into a Licensing Agreement
May 7, 2020
BetterLife Pharma Provides Shareholder Update
April 7, 2020
BetterLife Pharma Acquires Swiss Based Solmic AG with Unique Global Patent for Production of New Generation CBD based Biopharmaceuticals
February 3, 2020
BetterLife Pharma strengthens Board of Directors and Management
January 22, 2020
BetterLife Pharma files site evidence package with Health Canada
January 6, 2020